论文部分内容阅读
有效降压是高血压患者获益的基石,降压达标是高血压治疗的核心。降压治疗的目的不仅仅是降低血压水平,其最终的目的是有效降低靶器官损害的危险性,进而减少心血管终点事件的发生。循证医学证实了选择血管紧张素转换酶抑制剂+钙离子拮抗剂优化联合降压治疗方案对降压达标以及降低冠心病的发生率、病死率具有更明显的优势。
Effective antihypertensive benefit is the cornerstone of patients with hypertension, antihypertensive compliance is the core of hypertension treatment. The goal of antihypertensive therapy is not only to lower the blood pressure level, but its ultimate goal is to effectively reduce the risk of target organ damage, thereby reducing the occurrence of cardiovascular endpoints. Evidence-based medicine confirmed that the combination of angiotensin-converting enzyme inhibitor + calcium channel blocker and antihypertensive treatment regimen has the obvious advantage of lowering blood pressure and lowering the incidence of coronary heart disease and mortality.